Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Description

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

Official source

Beneficiarios elegibles

• Native American tribal organizations (other than Federally recognized tribal governments)
• State governments
• Native American tribal governments (Federally recognized)
• Public housing authorities/Indian housing authorities
• For profit organizations other than small businesses
• City or township governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Small businesses
• County governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• Special district governments
• Private institutions of higher education
• Public and State controlled institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)